Stanford School of Medicine
Cardiovascular Medicine In the Department of Medicine

Michael X. Pham, MD, MPH

Medical Director, Heart Failure/Transplant Program (VA)
Instructor of Medicine


Michael X. Pham, MD Clinical Profile

Medical School:

  • University of California, San Francisco
    San Francisco, CA
    1998

Clinical Interests:

  • Heart failure
  • Cardiac transplantation
  • Echocardiography

Board Certifications:

  • Internal Medicine
  • Cardiovascular Medicine

Research Interests:

  • Epidemiology and outcomes research
  • Gene expression profiling and allograft rejection
  • Coronary allograft vasculopathy: diagnosis, prevention, and risk stratification
  • Antibody mediated rejection: diagnosis and treatment

Selected Publications:

  • Pham MX, Deng MC, Kfoury AG, Teuteberg JJ, Starling RC, Valantine H. Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. J Heart Lung Transplant. 2007 Aug;26(8):808-14.
  • Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC; Working Group on Molecular Testing in Cardiac Transplantation. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant. 2006 Dec;25(12):1389-95.
  • Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J. 2005 Jul;150(1):161-7.
  • Pham MX, Whooley MA, Evans GT Jr, Liu C, Emadi H, Tong W, Murphy MC, Fleischmann KE. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J. 2004 Nov;148(5):776-82.
  • Pham MX, Hunt SA, Johnson FL. Cardiac xenotransplantation. Coron Artery Dis. 2004 Mar;15(2):99-105.

Institution Links:

Footer Links: